Product Information

DEFERASIROX 360 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.0484 per EA under NDC 59651041230. Its NADAC has been published 112 times since Oct 2, 2024.

FDA first approved this application on Oct 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEFERASIROX 360 MG TABLET

DEFERASIROX
$1.0484per EA

Strength

360 mg/1

NDC

59651041230

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DEFERASIROX

Approval Type

Generic (ANDA)

FDA Application

ANDA214474

FDA Approved

10/16/2023

TE Code

AB

On Market Since

10/16/2023

Pharmacological Classes

Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inducers
Iron Chelating Activity
Iron Chelator

Price Statistics

The NADAC for DEFERASIROX 360 MG TABLET has been published 112 times since Oct 2, 2024, and over the history we have for it it has declined 46.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0484 per EA
All-time high$1.9511 (Oct 16, 2024)
All-time low$1.0484 (Nov 18, 2026)
52-week high$1.6434
52-week low$1.0484
Median price$1.4097
Average price$1.4459
Largest weekly change+29.6% (Mar 18, 2026)
Weeks tracked112
Tracking sinceOct 2, 2024

Price History

1W

-6.3%

1M

-16.0%

3M

-21.8%

6M

-32.1%

1Y

-17.3%

3Y

N/A

5Y

N/A

All

-46.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEFERASIROX 360 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 360 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.0484 per EA (NDC 59651041230), effective Nov 18, 2026.

How has the price of DEFERASIROX 360 MG TABLET changed over time?

Over the history we have for it, the NADAC for DEFERASIROX 360 MG TABLET has declined 46.3%. It has been tracked across 112 weekly CMS publications since Oct 2, 2024.

What are the highest and lowest recorded NADAC prices for DEFERASIROX 360 MG TABLET?

Since Oct 2, 2024, the NADAC for DEFERASIROX 360 MG TABLET has ranged from a low of $1.0484 (Nov 18, 2026) to a high of $1.9511 (Oct 16, 2024), with a median of $1.4097 per EA.

Are there cheaper alternatives to DEFERASIROX 360 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEFERASIROX 360 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DEFERASIROX 360 MG TABLET?

DEFERASIROX 360 MG TABLET (NDC 59651041230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.